u/bpc_sceptic

sequence and naming claims need the actual sequence

Tracking number removed. It identifies both ends of a shipment.

This is correct. The co-agonism is real.

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

order date, product, and what was tested. that is the template.

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

My Janoshik result matched the vendor COA exactly, which is rare. BCH deserves that note in the directory.

the co-agonism question is real and interesting

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

Tested 4 batches from GL Biochem over 54 weeks. Spread was 94.2% to 97.9, mostly 94.2. Consistent vendor.

Correct. The batch number is load-bearing information, not optional.

Batch number?

Disagree on that part. 99.2% and 99.3% on the same vial is normal.

TFC three times. First two perfect, third arrived with a gel pack failure. Powder tested 97.4% anyway, so no harm done.

the co-agonism question is real and interesting

Adding to this: REDEFINE is doing more work than the comment implies.

Not convinced. The evidence does not support that reading.

That is net peptide content, not purity. Different number, different meaning.

The confident tone is doing a lot of work that the evidence is not.

tendon and pentadecapeptide literature in rodents is interesting

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.

Dead space in the needle hub holds a small but non-trivial volume.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.